Offer - Urjas Oil for just ₹ 1
Glaniknase is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Heart Attack, Pulmonary Embolism. Secondary and off-label uses of Glaniknase have also been mentioned below.
The optimal dosage of Glaniknase is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Glaniknase side effects, there are can be others also. These have been listed below. Usually, these side effects of Glaniknase go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Glaniknase's effect during pregnancy is Moderate and Moderate while nursing. In addition, Glaniknase's effects on the liver, heart and kidney are discussed below in the Glaniknase related warnings section.
Glaniknase is contraindicated in people with pre-existing medical conditions like Bleeding, Hemophilia, Drug Allergy as it can result in adverse effects.
Drug interactions for Glaniknase have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Glaniknase, it is important to know that it is safe while driving, and is habit-forming.
Glaniknase is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Glaniknase safe for pregnant women?
Glaniknase may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Glaniknase again without your doctor's advice.
Is the use of Glaniknase safe during breastfeeding?
Glaniknase can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Glaniknase on the Kidneys?
Glaniknase may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glaniknase on the Liver?
Side effects of Glaniknase rarely affect the liver.
What is the effect of Glaniknase on the Heart?
Very few cases of side effects of Glaniknase on the heart have been reported.
Glaniknase should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glaniknase unless your doctor advises you to do so -
Is this Glaniknase habit forming or addictive?
No, you will not get addicted to Glaniknase.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Glaniknase since it does not cause drowsiness.
Is it safe?
Yes, but take Glaniknase only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Glaniknase for mental disorders.
Interaction between Food and Glaniknase
Due to a lack of research, nothing can be said about the consequences of taking Glaniknase together with food.
Interaction between Alcohol and Glaniknase
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Glaniknase.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 626
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1198-1200
